The α,α-Difluorinated Phosphonate L-pSer-Analogue: An Accessible Chemical Tool for Studying Kinase- Dependent Signal Transduction

Chemistry and Biology

Volumn 16, Issue 9, 2009, Pages 928-936

  Panigrahi, Kaushik ^a   Eggen, MariJean ^a   Maeng, Jun Ho ^a   Shen, Quanrong ^a   Berkowitz, David B ^a,b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

CELLBIO; CHEMBIO; SIGNALING

Indexed keywords

CLODRONIC ACID; DIFLUOROMETHYLENE DIPHOSPHONATE; DRUG DERIVATIVE; MELATONIN; PHOSPHOSERINE; PROTEIN P53;

CHEMISTRY; METABOLISM; PHOSPHORYLATION; PROTEIN DOMAIN; REVIEW; SIGNAL TRANSDUCTION; SYNTHESIS;

CLODRONIC ACID; MAP KINASE SIGNALING SYSTEM; MELATONIN; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN INTERACTION DOMAINS AND MOTIFS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70349191367     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2009.08.008     Document Type: Review

References (111)

1. Banfi L., and Guanti G. Asymmetrized tris(hydroxymethyl)methane and related synthons. Enantioselective preparation and synthetic applications. Eur. J. Org. Chem. (1998) 745-757
2. Banfi L., Guanti G., Paravidino M., and Riva R. Asymmetrized tris(hydroxymethyl)methane as a precursor of N- and O-containing 6-membered heterocycles through ring-closing metathesis. Org. Biomol. Chem. 3 (2005) 1729-1737
3. Bell H.S., and Ryan K.M. Targeting the p53 family for cancer therapy: Big brother joins the fight. Cell Cycle 6 (2007) 1995-2000
4. Benayoud F., deMendonca D.J., Digits C.A., Moniz G.A., Sanders T.C., and Hammond G.B. Efficient syntheses of (alpha-fluoropropargyl)phosphonate esters. J. Org. Chem. 61 (1996) 5159-5164
5. Berkowitz D.B., and Bose M. (alpha-Monofluoroalkyl)phosphonates: a class of isoacidic and "tunable" mimics of biological phosphates. J. Fluor. Chem. 112 (2001) 13-33
6. Berkowitz D.B., and Sloss D.G. Diallyl (Lithiodifluoromethyl)phosphonate: A new reagent for the introduction of the (difluoromethylene)phosphonate functionality. J. Org. Chem. 60 (1995) 7047-7050
7. Berkowitz D.B., Eggen M., Shen Q., and Sloss D.G. Synthesis of (alpha,alpha-difluoroalkyl)phosphonates by displacement of primary triflates. J. Org. Chem. 58 (1993) 6174-6176
8. Berkowitz D.B., Pumphrey J.A., and Shen Q. Enantiomerically enriched alpha-vinyl amino acids via lipase-mediated reverse transesterification. Tetrahedron Lett. 35 (1994) 8743-8746
9. Berkowitz D.B., Shen Q., and Maeng J.-H. Synthesis of the (alpha, alpha-difluoroalkyl)phosphonate analog of phosphoserine. Tetrahedron Lett. 35 (1994) 6445-6448
10. Berkowitz D.B., Eggen M., Shen Q., and Shoemaker R.K. Ready access to fluorinated phosphonate mimics of secondary phosphates. Synthesis of the (alpha,alpha-Difluoroalkyl)phosphonate analogs of L-phosphoserine, L-phosphoallothreonine, and L-phosphothreonine. J. Org. Chem. 61 (1996) 4666-4675
11. Berkowitz D.B., Maeng J.-H., Dantzig A.H., Shepard R.L., and Norman B.H. Chemoenzymic and ring E-modular approach to the (-)-podophyllotoxin skeleton. Synthesis of 3′,4′,5′-tridemethoxy-(-)-podophyllotoxin. J. Am. Chem. Soc. 118 (1996) 9426-9427
12. Berkowitz D.B., Bhuniya D., and Peris G. Facile installation of the phosphonate and (alpha,alpha-difluoromethyl)phosphonate functionalities equipped with benzyl protection. Tetrahedron Lett. 40 (1999) 1869-1872
13. Berkowitz D.B., Bose M., Pfannenstiel T.J., and Doukov T. alpha-Fluorinated phosphonates as substrate mimics for glucose 6-phosphate dehydrogenase: the CHF stereochemistry matters. J. Org. Chem. 65 (2000) 4498-4508
14. Berkowitz D.B., Choi S., and Maeng J.-H. Enzyme-assisted asymmetric total synthesis of (-)-podophyllotoxin and (-)-picropodophyllin. J. Org. Chem. 65 (2000) 847-860
15. Berkowitz D.B., Bose M., and Asher N.G. A convergent triflate displacement approach to (alpha-monofluoroalkyl)phosphonates. Org. Lett. 3 (2001) 2009-2012
16. Berkowitz D.B., Maiti G., Charette B.D., Dreis C.D., and MacDonald R.G. Mono- and bivalent ligands bearing mannose 6-phosphate (M6P) surrogates: Targeting the M6P/insulin-like growth factor II receptor. Org. Lett. 6 (2004) 4921-4924
17. Biffinger J.C., Kim H.W., and DiMagno S.G. The polar hydrophobicity of fluorinated compounds. ChemBioChem 5 (2004) 622-627
18. Blackburn G.M., England D.A., and Kolkmann F. Monofluoro- and difluoromethylenebisphosphonic acids: isopolar analogs of pyrophosphoric acid. J. Chem. Soc. Chem. Commun. (1981) 930-932
19. Blackburn G.M., Kent D.E., and Kolkmann F. The synthesis and metal binding characteristics of novel, isopolar phosphonate analogs of nucleotides. J. Chem. Soc. Perkin 1 (1984) 1119-1125
20. Blackburn G.M., Brown D., and Martin S.J. A novel synthesis of fluorinated phosphonoacetic acids. J. Chem. Res. 3 (1985) 92-93
21. Blackburn G.M., Eckstein F., Kent D.E., and Perree T.D. Isopolar vs. isosteric phosphonate analogs of nucleotides. Nucleosides Nucleotides 4 (1985) 165-167
22. Blackburn G.M., Brown D., Martin S.J., and Parratt M.J. Studies on selected transformations of some fluoromethanephosphonate esters. J. Chem. Soc. Perkin 1 (1987) 181-186
23. Blackburn G.M., Jakeman D.L., Ivory A.J., and Williamson M.P. Synthesis of phosphonate analogs of 1,3-bisphosphoglyceric acid and their binding to yeast phosphoglycerate kinase. Bioorg. Med. Chem. Lett. 4 (1994) 2573-2578
24. Blades K., Lequeux T.P., and Percy J.M. A reproducible and high-yielding cerium-mediated route to alpha,alpha-difluoro-beta-ketophosphonates. Tetrahedron 53 (1997) 10623-10632
25. Boros L.G., and Boros T.F. Use of metabolic pathway flux information in anticancer drug design. Ernst Schering Found. Symp. Proc. 4 (2007) 189-203
26. Burton D.J., and Flynn R.M. Difluoromethanebis(phosphonic acid) Application: US 80-143995, 4330486 (1982), University of Iowa Research Foundation, USA pp. 5 pp.
27. Bykov V.J.N., Issaeva N., Shilov A., Hultcrantz M., Pugacheva L., Chumakov P., Bergman J., Wiman K.G., and Selivanova G. Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound. Nat. Med. 8 (2002) 282-288
28. Caplan N.A., Pogson C.I., Hayes D.J., and Blackburn G.M. The synthesis of novel bisphosphonates as inhibitors of phosphoglycerate kinase (3-PGK). Perkin 1 (2000) 421-437
29. Clarke A.J., Hurtado-Guerrero R., Pathak S., Schuttelkopf A.W., Borodkin V., Shepherd S.M., Ibrahim A.F.M., and van Aalten D.M.F. Structural insights into mechanism and specificity of O-GlcNAc transferase. EMBO J. 27 (2008) 2780-2788
30. Cockerill G.S., Easterfield H.J., Percy J.M., and Pintat S. Facile syntheses of building blocks for the construction of phosphotyrosine mimetics. Perkin 1 (2000) 2591-2599
31. Dawson P.E., Muir T.W., Clark-Lewis I., and Kent S.B.H. Synthesis of proteins by native chemical ligation. Science 266 (1994) 776-779
32. Di Croce L., and Shiekhattar R. Thrilling transcription through threonine phosphorylation. Nat. Cell Biol. 10 (2008) 5-6
33. Diab S.A., Sene A., Pfund E., and Lequeux T. Efficient synthesis of fluorophosphonylated alkyles by ring-opening reaction of cyclic sulfates. Org. Lett. 10 (2008) 3895-3898
34. DiMagno S.G., Dussault P.H., and Schultz J.A. Fluorous biphasic singlet oxygenation with a perfluoroalkylated photosensitizer. J. Am. Chem. Soc. 118 (1996) 5312-5313
35. Fei X., Connelly C.M., MacDonald R.G., and Berkowitz D.B. A set of phosphatase-inert "molecular rulers" to probe for bivalent mannose 6-phosphate ligand-receptor interactions. Bioorg. Med. Chem. Lett. 18 (2008) 3085-3089
36. Fernandez M.C., Diaz A., Guillin J.J., Blanco O., Ruiz M., and Ojea V. Diastereoselective synthesis of 2-amino-4-phosphonobutanoic acids by electrophilic substitution and tin-Peterson olefination of bis-lactim ethers derived from cyclo-. J. Org. Chem. 71 (2006) 6958-6974
37. Fiordaliso F., Leri A., Cesselli D., Limana F., Safai B., Nadal-Ginard B., Anversa P., and Kajstura J. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50 (2001) 2363-2375
38. Flavell R.R., and Muir T.W. Expressed protein ligation (EPL) in the study of signal transduction, ion conduction, and chromatin biology. Acc. Chem. Res. 42 (2009) 107-116
39. Franco M., and Tamagnone L. Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive. EMBO Rep. 9 (2008) 865-871
40. Garner P., and Park J.M. 1,1-Dimethylethyl (S)- or (R)-4-formyl-2,2-dimethyl-3-oxazolidinecarboxylate: a useful serinal derivative. Org. Synth. 70 (1992) 18-28
41. Gautier A., Lopin C., Garipova G., Kalinina I., Salcedo C., Balieu S., and Piettre S.R. Analogues of nucleotides and oligonucleotides featuring difluorophosphonate, difluorophosphonothioate and difluorophosphinate functional groups. J. Fluor. Chem. 125 (2004) 1745-1756
42. Girault J.-A. Signalling by tyrosine phosphorylation in the nervous system. In: Davies R.W., and Morris B.J. (Eds). Molecular Biology of the Neuron. Second Edition (2006), Oxford University Press, Oxford 271-289
43. Gorres K.L., Edupuganti R., Krow G.R., and Raines R.T. Conformational preferences of substrates for human prolyl 4-hydroxylase. Biochemistry 47 (2008) 9447-9455
44. Grangeasse C., Cozzone A.J., Deutscher J., and Mijakovic I. Tyrosine phosphorylation: an emerging regulatory device of bacterial physiology. Trends Biochem. Sci. 32 (2007) 86-94
45. Haltiwanger R.S., Busby S., Grove K., Li S., Mason D., Medina L., Moloney D., Philipsberg G., and Scartozzi R. O-glycosylation of nuclear and cytoplasmic proteins: regulation analogous to phosphorylation?. Biochem. Biophys. Res. Commun. 231 (1997) 237-242
46. Han E.-S., Muller F.L., Perez V.I., Qi W., Liang H., Xi L., Fu C., Doyle E., Hickey M., Cornell J., et al. The in vivo gene expression signature of oxidative stress. Physiol. Genomics 34 (2008) 112-126
47. Hart G.W., Greis K.D., Dong L.Y.D., Blomberg M.A., Chou T.-Y., Jiang M.-S., Roquemore E.P., Snow D.M., Kreppel L.K., Cole R.N., et al. O-linked N-acetylglucosamine: The "Yin-Yang" of Ser/Thr phosphorylation? Nuclear and cytoplasmic glycosylation. Adv. Exp. Med. Biol. 376 (1995) 115-123
48. Haupt S., and Haupt Y. Importance of p53 for cancer onset and therapy. Anticancer Drugs 17 (2006) 725-732
49. Herpin T.F., Houlton J.S., Motherwell W.B., Roberts B.P., and Weibel J.-M. Preparation of some new anomeric carbohydrate difluoromethylenephosphonates via phosphonyl radical addition to gem-difluoroenol ethers. Chem. Commun. (Camb.) (1996) 613-614
50. thEuropean Peptide Symposium, Montpellier, France, September 10-15, 2000, pp. 869-870.
51. Higashimoto Y., Saito S., Tong X.H., Hong A., Sakaguchi K., Appella E., and Anderson C.W. Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents. J. Biol. Chem. 275 (2000) 23199-23203
52. Hikishima S., Isobe M., Koyanagi S., Soeda S., Shimeno H., Shibuya S., and Yokomatsu T. Synthesis and biological evaluation of 9-(5′,5′-difluoro-5′-phosphonopentyl)guanine derivatives for PNP-inhibitors. Bioorg. Med. Chem. 14 (2006) 1660-1670
53. Jensen J., and Lai Y.-C. Regulation of muscle glycogen synthase phosphorylation and kinetic properties by insulin, exercise, adrenaline and role in insulin resistance. Arch. Physiol. Biochem. 115 (2009) 13-29
54. Kawamoto A.M., and Campbell M.M. A new method for the synthesis of a phosphonic acid analog of phosphoserine via a novel 1,1-difluorophosphonate intermediate. J. Fluor. Chem. 81 (1997) 181-186
55. Kishi H., Nakagawa K., Matsumoto M., Suga M., Ando M., Taya Y., and Yamaizumi M. Osmotic shock induces G1 arrest through p53 phosphorylation at Ser33 by activated p38MAPK without phosphorylation at Ser15 and Ser20. J. Biol. Chem. 276 (2001) 39115-39122
56. Klein D.C. Arylalkylamine N-acetyltransferase: the timezyme. J. Biol. Chem. 282 (2007) 4233-4237
57. Klein D.C., Ganguly S., Coon S.L., Shi Q., Gaildrat P., Morin F., Weller J.L., Obsil T., Hickman A., and Dyda F. 14-3-3 proteins in pineal photoneuroendocrine transduction: How many roles?. J. Neuroendocrinol. 15 (2003) 370-377
58. Kulasekara H.D., and Miller S.I. Threonine phosphorylation times bacterial secretion. Nat. Cell Biol. 9 (2007) 734-736
59. Lequeux T., Lebouc F., Lopin C., Yang H., Gouhier G., and Piettre S.R. Sulfanyl- and selanyldifluoromethylphosphonates as a source of phosphonodifluoromethyl radicals and their addition onto alkenes. Org. Lett. 3 (2001) 185-188
60. Liebermann D.A., Hoffman B., and Vesely D. p53 Induced growth arrest versus apoptosis and its modulation by survival cytokines. Cell Cycle 6 (2007) 166-170
61. Liu D.R., and Schultz P.G. Progress toward the evolution of an organism with an expanded genetic code. Proc. Natl. Acad. Sci. USA 96 (1999) 4780-4785
62. Lopin C., Gouhier G., and Piettre S.R. First synthesis of S,S-dialkyl difluorophosphonodithioates and difluorophosphonotrithioates. Tetrahedron Lett. 44 (2003) 8837-8840
63. Martin S.F., Dean D.W., and Wagman A.S. A general method for the synthesis of 1,1-difluoroalkylphosphonates. Tetrahedron Lett. 33 (1992) 1839-1842
64. McKenna C.E., and Shen P.-D. Fluorination of methanediphosphonate esters by perchloryl fluoride. Synthesis of fluoromethanediphosphonic acid and difluoromethanediphosphonic acid. J. Org. Chem. 46 (1981) 4573-4576
65. Muir T.W., Sondhi D., and Cole P.A. Expressed protein ligation: A general method for protein engineering. Proc. Natl. Acad. Sci. USA 95 (1998) 6705-6710
66. Murano T., Kobayakawa H., Yuasa Y., Yokomatsu T., and Shibuya S. Improved synthesis of 1,3-propanediol derivatives having a diethoxyphosphoryldifluoroethyl functional group at the 2-position: application to chemoenzymatic synthesis of novel acyclic nucleotide analogues of adenosine bisphosphates. Synthesis (2005) 187-192
67. Nag K., and Chaudhary A. Mediators of tyrosine phosphorylation in innate immunity: from host defense to inflammation onto oncogenesis. Curr Signal Transduction Ther 4 (2009) 76-81
68. Nair H.K., and Burton D.J. Facile synthesis of fluorinated phosphonates via photochemical and thermal reactions. J. Am. Chem. Soc. 119 (1997) 9137-9143
69. Nieschalk J., Batsanov A.S., O'Hagan D., and Howard J.A.K. Synthesis of monofluoro- and difluoromethylenephosphonate analogs of sn-glycerol-3-phosphate as substrates for glycerol-3-phosphate dehydrogenase and the x-ray structure of the fluoromethylenephosphonate moiety. Tetrahedron 52 (1996) 165-176
70. O'Hagan D. Understanding organofluorine chemistry. An introduction to the C-F bond. Chem. Soc. Rev. 37 (2008) 308-319
71. Obsil T., Ghirlando R., Klein D.C., Ganguly S., and Dyda F. Crystal structure of the 14-3-3Œ-zeta:serotonin N-acetyltransferase complex: a role for scaffolding in enzyme regulation. Cell 105 (2001) 257-267
72. 2-substituted phosphothreonine mimetics and their incorporation into peptides using newly developed deprotection procedures. J. Org. Chem. 65 (2000) 4888-4899
73. Otaka A., Mitsuyama E., Watanabe J., Watanabe H., and Fujii N. Synthesis of fluorine-containing bioisosteres corresponding to phosphoamino acids and dipeptide units. Biopolymers 76 (2004) 140-149
74. Otaka A., Miyoshi K., Burke Jr. T.R., Roller P.P., Kubota H., Tamamura H., and Fujii N. Synthesis and application of N-Boc-L-2-amino-4-(diethylphosphono)-4,4-difluorobutanoic acid for solid-phase synthesis of nonhydrolyzable phosphoserine peptide analogs. Tetrahedron Lett. 36 (1995) 927-930
75. Otaka A., Miyoshi K., Kaneko M., Burke Jr. T.R., Roller P.P., Tamamura H., and Fujii N. Synthesis and biological activity of phosphatases resistant phosphoamino acid mimetics containing peptides. Pept Chem 32 (1995) 9-12
76. Ozouf P., Binot G., Pommelet J.-C., and Lequeux T.P. Syntheses of omega-hydroxy-alpha,alpha-difluoromethylphosphonates by oxacycle ring-opening reactions. Org. Lett. 6 (2004) 3747-3750
77. 4 and Grignard reagent-promoted ring-opening reactions of various epoxides: synthesis of gamma-hydroxy-alpha,alpha-difluoromethylenephosphonates. Tetrahedron Lett. 49 (2008) 6046-6049
78. Pfund E., Lequeux T., Masson S., Vazeux M., Cordi A., Pierre A., Serre V., and Herve G. Efficient synthesis of fluorothiosparfosic acid analogues with potential antitumoral activity. Bioorg. Med. Chem. 13 (2005) 4921-4928
79. Pickin K.A., Chaudhury S., Dancy B.C.R., Gray J.J., and Cole P.A. Analysis of protein kinase autophosphorylation using expressed protein ligation and computational modeling. J. Am. Chem. Soc. 130 (2008) 5667-5669
80. Pignard S., Lopin C., Gouhier G., and Piettre S.R. Phosphonodifluoromethyl and phosphonothiodifluoromethyl radicals. Generation and addition onto alkenes and alkynes. J. Org. Chem. 71 (2006) 31-37
81. Pytel D., Sliwinski T., Poplawski T., Ferriola D., and Majsterek I. Tyrosine kinase blockers: new hope for successful cancer therapy. Anticancer. Agents Med. Chem. 9 (2009) 66-76
82. Rauh D., and Waldmann H. Linking chemistry and biology for the study of protein function. Angew. Chem. Int. Ed. 46 (2007) 826-829
83. Roeschenthaler G.-V., Kukhar V.P., Belik M.Y., Mazurenko K.I., and Sorochinsky A.E. Diastereoselective addition of diethyl difluoromethylphosphonate to enantiopure sulfinimines: synthesis of alpha,alpha-difluoro-beta-aminophosphonates, phosphonic acids, and phosphonamidic acids. Tetrahedron 62 (2006) 9902-9910
84. Roskoski R. VEGF receptor protein-tyrosine kinases: Structure and regulation. Biochem. Biophys. Res. Commun. 375 (2008) 287-291
85. Saito S.I., Yamaguchi H., Higashimoto Y., Chao C., Xu Y., Fornace Jr. A.J., Appella E., and Anderson C.W. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J. Biol. Chem. 278 (2003) 37536-37544
86. Savage M.J., and Gingrich D.E. Advances in the development of kinase inhibitor therapeutics for Alzheimer's disease. Drug Dev. Res. 70 (2009) 125-144
87. Schwarzer D., and Cole P.A. Protein semisynthesis and expressed protein ligation: chasing a protein's tail. Curr. Opin. Chem. Biol. 9 (2005) 561-569
88. Shen Q., Sloss D.G., and Berkowitz D.B. Displacement of sugar triflates with C-nucleophiles: D-glucopyranose and D-ribofuranose chain extension and functionalization. Synth. Commun. 24 (1994) 1519-1530
89. Sherr C.J. Principles of tumor suppression. Cell 116 (2004) 235-246
90. Sunahara R.K., Dessauer C.W., and Gilman A.G. Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol. 36 (1996) 461-480
91. Szewczuk L.M., Tarrant M.K., Sample V., Drury W.J., Zhang J., and Cole P.A. Analysis of serotonin N-acetyltransferase regulation in vitro and in live cells using protein semisynthesis. Biochemistry 47 (2008) 10407-10419
92. Toledo F., and Wahl G.M. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer 6 (2006) 909-923
93. Toole B.J., and Cohen P.T.W. The skeletal muscle-specific glycogen-targeted protein phosphatase 1 plays a major role in the regulation of glycogen metabolism by adrenaline in vivo. Cell. Signal. 19 (2007) 1044-1055
94. Tzivion G., and Avruch J. 14-3-3 Proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J. Biol. Chem. 277 (2002) 3061-3064
95. Vassilev L.T. p53 Activation by small molecules: Application in oncology. J. Med. Chem. 48 (2005) 4491-4499
96. Vassilev L.T., Vu B.T., Graves B., Carvajal D., Podlaski F., Filipovic Z., Kong N., Kammlott U., Lukacs C., Klein C., et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303 (2004) 844-848
97. Ventura A., Kirsch D.G., McLaughlin M.E., Tuveson D.A., Grimm J., Lintault L., Newman J., Reczek E.E., Weissleder R., and Jacks T. Restoration of p53 function leads to tumor regression in vivo. Nature 445 (2007) 661-665
98. Welch J.T. Fluoroolefin dipeptide isosteres: structure, syntheses, and applications. Fluorine and Health (2008) 699-735
99. Wells L., Whalen S.A., and Hart G.W. O-GlcNAc: a regulatory post-translational modification. Biochem. Biophys. Res. Commun. 302 (2003) 435-441
100. Xie J., and Schultz P.G. Adding amino acids to the genetic repertoire. Curr. Opin. Chem. Biol. 9 (2005) 548-554
101. Xie J., and Schultz P.G. A chemical toolkit for proteins - an expanded genetic code. Nat. Rev. Mol. Cell Biol. 7 (2006) 775-782
102. Xu Y., Aoki J., Shimizu K., Umezu-Goto M., Hama K., Takanezawa Y., Yu S., Mills G.B., Arai H., Qian L., et al. Structure-activity relationships of fluorinated lysophosphatidic acid analogues. J. Med. Chem. 48 (2005) 3319-3327
103. Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., Cordon-Cardo C., and Lowe S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007) 656-660
104. Yamauchi M., Suzuki K., Kodama S., and Watanabe M. Stabilization of alanine-substituted p53 protein at Ser15, Thr18, and Ser20 in response to ionizing radiation. Biochem. Biophys. Res. Commun. 323 (2004) 906-911
105. Yang Z.Y., and Burton D.J. A novel and practical preparation of alpha,alpha-difluoro functionalized phosphonates from iododifluoromethylphosphonate. J. Org. Chem. 57 (1992) 4676-4683
106. Yokomatsu T., Kato J., Sakuma C., and Shibuya S. Stereoselective synthesis of highly-functionalized cyclohexene derivatives having a diethoxyphosphoryldifluoromethyl functionality from cyclohex-2-enyl-1-phosphates. Synlett (2003) 1407-1410
107. Yokomatsu T., Sato M., and Shibuya S. Lipase-catalyzed enantioselective acylation of prochiral 2-(omega-phosphono)alkyl-1,3-propanediols: application to the enantioselective synthesis of omega-phosphono-alpha-amino acids. Tetrahedron Asymmetry 7 (1996) 2743-2754
108. Zhang Z., Shen K., Lu W., and Cole P.A. The role of C-terminal tyrosine phosphorylation in the regulation of SHP-1 explored via expressed protein ligation. J. Biol. Chem. 278 (2003) 4668-4674
109. Zhang G., Xu C.-F., and Neubert T.A. Analysis of protein-tyrosine phosphorylation by mass spectrometry. Compr. Anal. Chem. 52 (2009) 297-313
110. Zheng W., Zhang Z., Ganguly S., Weller J.L., Klein D.C., and Cole P.A. Cellular stabilization of the melatonin rhythm enzyme induced by nonhydrolyzable phosphonate incorporation. Nat. Struct. Biol. 10 (2003) 1054-1057
111. Zheng W., Schwarzer D., LeBeau A., Weller J.L., Klein D.C., and Cole P.A. Cellular stability of serotonin N-acetyltransferase conferred by phosphonodifluoromethylene alanine (Pfa) substitution for Ser-205. J. Biol. Chem. 280 (2005) 10462-10467